Bank of America’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bank of America’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.6M	Buy	456,606 +12,565	+3%	+$1.1M	﹤0.01%	1782
2025 Q4	$37.7M	Buy	444,041 +329,332	+287%	+$26.3M	﹤0.01%	1756
2025 Q3	$8.32M	Sell	114,709 -6,960	-6%	-$480K	﹤0.01%	3481
2025 Q2	$7.97M	Sell	121,669 -19,161	-14%	-$1.25M	﹤0.01%	3431
2025 Q1	$9.94M	Sell	140,830 -23,388	-14%	-$1.63M	﹤0.01%	3141
2024 Q4	$10.8M	Buy	164,218 +9,086	+6%	+$625K	﹤0.01%	2866
2024 Q3	$11M	Sell	155,132 -855	-0.5%	-$59.6K	﹤0.01%	2979
2024 Q2	$10.3M	Sell	155,987 -9,507	-6%	-$623K	﹤0.01%	2921
2024 Q1	$11.2M	Sell	165,494 -35,902	-18%	-$2.37M	﹤0.01%	2881
2023 Q4	$12.4M	Buy	201,396 +109,596	+119%	+$6.44M	﹤0.01%	2635
2023 Q3	$5.42M	Buy	91,800 +681	+0.7%	+$41.8K	﹤0.01%	3332
2023 Q2	$5.44M	Sell	91,119 -21,900	-19%	-$1.3M	﹤0.01%	3321
2023 Q1	$6.6M	Sell	113,019 -561	-0.5%	-$33.8K	﹤0.01%	3247
2022 Q4	$7.05M	Sell	113,580 -67,212	-37%	-$4.04M	﹤0.01%	3039
2022 Q3	$10.2M	Buy	180,792 +8,673	+5%	+$534K	﹤0.01%	2595
2022 Q2	$11M	Buy	172,119 +44,199	+35%	+$2.81M	﹤0.01%	2581
2022 Q1	$8.28M	Buy	127,920 +26,676	+26%	+$1.69M	﹤0.01%	3046
2021 Q4	$6.74M	Buy	101,244 +22,791	+29%	+$1.45M	﹤0.01%	3356
2021 Q3	$4.79M	Sell	78,453 -15,582	-17%	-$991K	﹤0.01%	3609
2021 Q2	$5.82M	Sell	94,035 -5,889	-6%	-$358K	﹤0.01%	3381
2021 Q1	$5.92M	Sell	99,924 -2,043	-2%	-$123K	﹤0.01%	3240
2020 Q4	$6.1M	Buy	101,967 +17,082	+20%	+$974K	﹤0.01%	2947
2020 Q3	$4.63M	Buy	84,885 +10,473	+14%	+$565K	﹤0.01%	2983
2020 Q2	$3.82M	Buy	74,412 +3,282	+5%	+$165K	﹤0.01%	3081
2020 Q1	$3.19M	Sell	71,130 -23,334	-25%	-$1.18M	﹤0.01%	3099
2019 Q4	$5.04M	Buy	94,464 +35,928	+61%	+$1.77M	﹤0.01%	3239
2019 Q3	$2.73M	Sell	58,536 -2,352	-4%	-$113K	﹤0.01%	3781
2019 Q2	$3.06M	Sell	60,888 -15,885	-21%	-$785K	﹤0.01%	3675
2019 Q1	$3.94M	Sell	76,773 -5,151	-6%	-$256K	﹤0.01%	3388
2018 Q4	$3.84M	Sell	81,924 -52,263	-39%	-$2.68M	﹤0.01%	3268
2018 Q3	$7.51M	Buy	134,187 +19,584	+17%	+$1.07M	﹤0.01%	2787
2018 Q2	$5.78M	Sell	114,603 -85,101	-43%	-$4.22M	﹤0.01%	3015
2018 Q1	$9.82M	Sell	199,704 -46,137	-19%	-$2.37M	﹤0.01%	2429
2017 Q4	$12.7M	Sell	245,841 -126,198	-34%	-$6.48M	﹤0.01%	2228
2017 Q3	$19.4M	Sell	372,039 -144,363	-28%	-$7.41M	﹤0.01%	1900
2017 Q2	$26.7M	Buy	516,402 +16,842	+3%	+$851K	0.01%	1487
2017 Q1	$25.1M	Sell	499,560 -179,247	-26%	-$8.87M	0.01%	1556
2016 Q4	$32M	Buy	678,807 +330,666	+95%	+$15.7M	0.01%	1293
2016 Q3	$17.3M	Sell	348,141 -39,435	-10%	-$2M	﹤0.01%	1753
2016 Q2	$18.7M	Sell	387,576 -103,194	-21%	-$4.91M	﹤0.01%	1635
2016 Q1	$22.4M	Sell	490,770 -222,123	-31%	-$10.4M	0.01%	1477
2015 Q4	$38.4M	Sell	712,893 -70,074	-9%	-$3.69M	0.01%	1163
2015 Q3	$38.6M	Buy	782,967 +16,752	+2%	+$960K	0.01%	1151
2015 Q2	$44.7M	Buy	766,215 +21,522	+3%	+$1.26M	0.01%	915
2015 Q1	$42.8M	Sell	744,693 -78,993	-10%	-$4.32M	0.01%	897
2014 Q4	$41.6M	Sell	823,686 -47,142	-5%	-$2.3M	0.01%	944
2014 Q3	$40.7M	Buy	870,828 +79,485	+10%	+$3.59M	0.01%	946
2014 Q2	$35.6M	Buy	791,343 +144,084	+22%	+$6.2M	0.01%	1016
2014 Q1	$27.3M	Buy	647,259 +23,136	+4%	+$970K	0.01%	1074
2013 Q4	$24.6M	Sell	624,123 -17,736	-3%	-$665K	0.01%	1192
2013 Q3	$22.8M	Sell	641,859 -52,203	-8%	-$1.84M	0.01%	1183
2013 Q2	$23.1M	Buy	+694,062	New	+$23.1M	0.01%	1097

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America's IHE Position: Q1 2026 in Review

Bank of America increased its iShares US Pharmaceuticals ETF (IHE) stake by 2.8% in Q1 2026, buying an estimated $1.1M and bringing the position to 456,606 shares worth $39.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Bank of America first reported a position in IHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $44.7M in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Bank of America held 456,606 shares of iShares US Pharmaceuticals ETF worth $39.6M as of Q1 2026.
Bank of America bought 12,565 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $1.1M.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1782 holding.
Bank of America first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
Bank of America's iShares US Pharmaceuticals ETF position peaked at $44.7M in Q2 2015.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.